Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
26.8%
% of GNOM's 41 holdings also in IDNA
23.4%
% of IDNA's 51 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
MODERNA, INC. | 4.1% | 4.7% | 4.1% |
|
SAREPTA THERAPEUTICS INC | 3.6% | 5.5% | 3.6% |
 |
BIONTECH SE SPONSORED ADR | 2.9% | 3.4% | 2.9% |
|
BEAM THERAPEUTICS, INC. | 3.2% | 2.5% | 2.5% |
|
GILEAD SCIENCES INC | 1.4% | 3.3% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to IDNA
|
NATERA INC | 7.4% |
 |
ENI SPA-SPONSORED ADR | 7.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | 4.7% |
|
AGILENT TECHNOLOGIES INC | 4.3% |
|
CRISPR THERAPEUTICS AG | 3.9% |
|
ILLUMINA INC | 3.5% |
|
BIO-TECHNE CORPORATION | 3.4% |
|
QIAGEN NV | 3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.3% |
|
BIOMARIN PHARMACEUTICAL INC | 3.3% |
GNOM Underweight Relative to IDNA
|
REVOLUTION MEDICINES, INC. | -4.7% |
|
MERCK & CO. INC. | -4.6% |
|
REGENERON PHARMACEUTICALS | -4.3% |
|
EXELIXIS INC | -3.9% |
|
INCYTE CORP | -3.8% |
 |
SANOFI-AVENTIS | -3.7% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -3.5% |
 |
GENMAB A/S | -3.5% |
|
IOVANCE BIOTHERAPEUTICS INC | -3.4% |
 |
ROCHE HOLDING LTD | -3.3% |